Case studies from aviation and pharmaceuticals demonstrate why we don't fly in unapproved planes or take untested drugs—so why do we deploy untested AI for critical decisions?
Case studies from aviation and pharmaceuticals highlight the crucial need for responsible regulatory bodies and governance. There is an absurdity in continuing with untested AI systems. The use of technology is directly connected to daily risk management across various sectors. Policymakers and the public should advocate for certification-like processes for AI. We don't fly unapproved planes or take untested drugs. So why deploy untested AI for critical decisions? Safety-first cultures in aviation and pharma show the standard AI must meet before lives are at risk.
Deep dive into real-world examples and case studies
Evidence-based framework connections and practical applications
Actionable takeaways for immediate implementation
This video directly supports Pillar 1 of the Bridge Framework: Bias & Fairness
Explore Full FrameworkBased on topics, keywords, and content similarity



Assess your organisation's AI governance maturity and get personalised recommendations.
Take AssessmentResource Name
Secure download • No credit card required